Business & Finance
Labcorp Raises Earnings Outlook on Strong Medical Testing Demand
Key Points
Labcorp Raises Earnings Outlook on Strong Medical Testing Demand Labcorp Holdings Inc. raised its outlook for the year after reporting second-quarter earnings that topped analyst estimates, citing strength in cancer tests and new genetic screenings. The medical testing company now expects adjusted earnings of $18.10 to $18.55 a share for the year, an increase of 30 cents at the midpoint. Adjusted profit in the quarter was higher than the average of analyst estimates in a Bloomberg survey.
Labcorp Raises Earnings Outlook on Strong Medical Testing Demand
Labcorp Holdings Inc. raised its outlook for the year after reporting second-quarter earnings that topped analyst estimates, citing strength in cancer tests and new genetic screenings.
The medical testing company now expects adjusted earnings of $18.10 to $18.55 a share for the year, an increase of 30 cents at the midpoint. Adjusted profit in the quarter was higher than the average of analyst estimates in a Bloomberg survey.